nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—CYP1A2—chronic obstructive pulmonary disease	0.236	0.542	CbGaD
Cisapride—HTR2A—chronic obstructive pulmonary disease	0.199	0.458	CbGaD
Cisapride—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0627	0.13	CbGbCtD
Cisapride—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0627	0.13	CbGbCtD
Cisapride—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0475	0.0985	CbGbCtD
Cisapride—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0279	0.0578	CbGbCtD
Cisapride—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0259	0.0538	CbGbCtD
Cisapride—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0259	0.0538	CbGbCtD
Cisapride—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0234	0.0486	CbGbCtD
Cisapride—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0215	0.0447	CbGbCtD
Cisapride—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0215	0.0447	CbGbCtD
Cisapride—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0203	0.0422	CbGbCtD
Cisapride—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0197	0.0409	CbGbCtD
Cisapride—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0197	0.0409	CbGbCtD
Cisapride—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0176	0.0364	CbGbCtD
Cisapride—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0165	0.0343	CbGbCtD
Cisapride—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0163	0.0339	CbGbCtD
Cisapride—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0112	0.0232	CbGbCtD
Cisapride—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0109	0.0226	CbGbCtD
Cisapride—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0107	0.0221	CbGbCtD
Cisapride—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00949	0.0197	CbGbCtD
Cisapride—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00557	0.0116	CbGbCtD
Cisapride—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00526	0.0109	CbGbCtD
Cisapride—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00449	0.382	CbGeAlD
Cisapride—Gefitinib—ERBB3—chronic obstructive pulmonary disease	0.00168	0.403	CrCbGaD
Cisapride—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00163	0.138	CbGeAlD
Cisapride—Gefitinib—EGFR—chronic obstructive pulmonary disease	0.000753	0.181	CrCbGaD
Cisapride—HTR3A—respiratory system—chronic obstructive pulmonary disease	0.00068	0.0577	CbGeAlD
Cisapride—Iloperidone—CYP1A2—chronic obstructive pulmonary disease	0.000577	0.138	CrCbGaD
Cisapride—Iloperidone—HTR2A—chronic obstructive pulmonary disease	0.000487	0.117	CrCbGaD
Cisapride—Gefitinib—CYP1A1—chronic obstructive pulmonary disease	0.000431	0.103	CrCbGaD
Cisapride—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000416	0.0353	CbGeAlD
Cisapride—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000414	0.0351	CbGeAlD
Cisapride—HTR3A—lung—chronic obstructive pulmonary disease	0.000361	0.0307	CbGeAlD
Cisapride—CYP2A6—lung—chronic obstructive pulmonary disease	0.000355	0.0301	CbGeAlD
Cisapride—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000351	0.0298	CbGeAlD
Cisapride—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000338	0.0287	CbGeAlD
Cisapride—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000336	0.0286	CbGeAlD
Cisapride—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000277	0.0235	CbGeAlD
Cisapride—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000274	0.0233	CbGeAlD
Cisapride—HTR2B—lung—chronic obstructive pulmonary disease	0.000273	0.0232	CbGeAlD
Cisapride—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000242	0.0205	CbGeAlD
Cisapride—Gefitinib—ALB—chronic obstructive pulmonary disease	0.00024	0.0576	CrCbGaD
Cisapride—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000221	0.0188	CbGeAlD
Cisapride—DRD2—lung—chronic obstructive pulmonary disease	0.000221	0.0188	CbGeAlD
Cisapride—HTR2A—trachea—chronic obstructive pulmonary disease	0.000203	0.0172	CbGeAlD
Cisapride—CYP1A2—lung—chronic obstructive pulmonary disease	0.000186	0.0158	CbGeAlD
Cisapride—CYP3A5—lung—chronic obstructive pulmonary disease	0.00018	0.0153	CbGeAlD
Cisapride—CYP2B6—lung—chronic obstructive pulmonary disease	0.000179	0.0152	CbGeAlD
Cisapride—HTR2A—lung—chronic obstructive pulmonary disease	0.000146	0.0124	CbGeAlD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.93e-05	0.000285	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.9e-05	0.000281	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.89e-05	0.000279	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.88e-05	0.000278	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.87e-05	0.000277	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.86e-05	0.000275	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.85e-05	0.000274	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.82e-05	0.00027	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.82e-05	0.00027	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.81e-05	0.000268	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.79e-05	0.000266	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.79e-05	0.000266	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.79e-05	0.000265	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.77e-05	0.000263	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.77e-05	0.000262	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.74e-05	0.000258	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.73e-05	0.000257	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.72e-05	0.000254	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.71e-05	0.000254	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.71e-05	0.000254	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.69e-05	0.00025	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	1.69e-05	0.00025	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.68e-05	0.000248	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.66e-05	0.000246	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.66e-05	0.000246	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.66e-05	0.000246	CbGpPWpGaD
Cisapride—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.66e-05	0.000245	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.65e-05	0.000245	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.65e-05	0.000244	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000244	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.63e-05	0.000242	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.62e-05	0.00024	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.000236	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.59e-05	0.000235	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.000234	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.57e-05	0.000233	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.000232	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.56e-05	0.000231	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.54e-05	0.000229	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.53e-05	0.000227	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.53e-05	0.000227	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.000226	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.52e-05	0.000225	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.52e-05	0.000225	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.51e-05	0.000224	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.51e-05	0.000224	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.51e-05	0.000223	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.5e-05	0.000223	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.000218	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.47e-05	0.000218	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.47e-05	0.000217	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.44e-05	0.000214	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.44e-05	0.000214	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.44e-05	0.000213	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.44e-05	0.000213	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.44e-05	0.000213	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.43e-05	0.000212	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.42e-05	0.00021	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.4e-05	0.000208	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.39e-05	0.000206	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.38e-05	0.000205	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.000205	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.37e-05	0.000203	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.34e-05	0.000199	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.32e-05	0.000196	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.31e-05	0.000195	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.29e-05	0.000192	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.29e-05	0.000192	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.28e-05	0.00019	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.28e-05	0.00019	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.27e-05	0.000188	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.25e-05	0.000186	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.24e-05	0.000183	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.22e-05	0.000181	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.22e-05	0.00018	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.000178	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000177	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.19e-05	0.000176	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000176	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.16e-05	0.000173	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.16e-05	0.000172	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000171	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.16e-05	0.000171	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.13e-05	0.000168	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.13e-05	0.000167	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000164	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.1e-05	0.000163	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.1e-05	0.000162	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000161	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000161	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.07e-05	0.000159	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.07e-05	0.000159	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.07e-05	0.000158	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.07e-05	0.000158	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.000157	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.06e-05	0.000156	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.05e-05	0.000156	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	0.000155	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.04e-05	0.000155	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.04e-05	0.000154	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000152	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.01e-05	0.00015	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.01e-05	0.00015	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1e-05	0.000148	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.98e-06	0.000148	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.91e-06	0.000147	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.82e-06	0.000145	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	9.79e-06	0.000145	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.77e-06	0.000145	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.69e-06	0.000144	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.59e-06	0.000142	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	9.58e-06	0.000142	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.4e-06	0.000139	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.4e-06	0.000139	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.33e-06	0.000138	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.21e-06	0.000136	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.06e-06	0.000134	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.02e-06	0.000134	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.94e-06	0.000132	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.93e-06	0.000132	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.91e-06	0.000132	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.89e-06	0.000132	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.83e-06	0.000131	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.81e-06	0.00013	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.76e-06	0.00013	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	8.74e-06	0.000129	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	8.73e-06	0.000129	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.69e-06	0.000129	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.57e-06	0.000127	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.53e-06	0.000126	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.48e-06	0.000126	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.29e-06	0.000123	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.23e-06	0.000122	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.17e-06	0.000121	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.16e-06	0.000121	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.16e-06	0.000121	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.14e-06	0.000121	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.1e-06	0.00012	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.05e-06	0.000119	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.04e-06	0.000119	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.98e-06	0.000118	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.97e-06	0.000118	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.74e-06	0.000115	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.73e-06	0.000115	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.58e-06	0.000112	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.57e-06	0.000112	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.55e-06	0.000112	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.53e-06	0.000112	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.52e-06	0.000111	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.48e-06	0.000111	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.46e-06	0.000111	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.42e-06	0.00011	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.41e-06	0.00011	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.4e-06	0.00011	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.38e-06	0.000109	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.36e-06	0.000109	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.34e-06	0.000109	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.2e-06	0.000107	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	7.11e-06	0.000105	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.04e-06	0.000104	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.96e-06	0.000103	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.91e-06	0.000102	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.81e-06	0.000101	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	6.81e-06	0.000101	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.71e-06	9.95e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.69e-06	9.92e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.62e-06	9.81e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.59e-06	9.76e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.55e-06	9.71e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	6.52e-06	9.66e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.25e-06	9.26e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.24e-06	9.24e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.24e-06	9.24e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.18e-06	9.15e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.17e-06	9.14e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.12e-06	9.07e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.09e-06	9.02e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.04e-06	8.95e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.95e-06	8.82e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.94e-06	8.8e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.85e-06	8.67e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.83e-06	8.63e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.76e-06	8.53e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.68e-06	8.42e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.68e-06	8.41e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.65e-06	8.37e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.63e-06	8.34e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.5e-06	8.15e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.42e-06	8.02e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.38e-06	7.97e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.33e-06	7.9e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	5.26e-06	7.8e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.25e-06	7.78e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.25e-06	7.78e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.23e-06	7.75e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.17e-06	7.66e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.16e-06	7.64e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.14e-06	7.62e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.07e-06	7.52e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.04e-06	7.47e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.03e-06	7.46e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.01e-06	7.43e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.93e-06	7.31e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.92e-06	7.29e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.84e-06	7.17e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.81e-06	7.12e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.79e-06	7.1e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.66e-06	6.9e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.57e-06	6.76e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.56e-06	6.75e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.56e-06	6.75e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.45e-06	6.6e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.45e-06	6.59e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.38e-06	6.48e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.26e-06	6.31e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.23e-06	6.27e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.16e-06	6.17e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.09e-06	6.06e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.04e-06	5.98e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.02e-06	5.96e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.98e-06	5.9e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.98e-06	5.89e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.96e-06	5.86e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.83e-06	5.68e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.8e-06	5.63e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.76e-06	5.57e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.71e-06	5.5e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.68e-06	5.46e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.66e-06	5.42e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.63e-06	5.37e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.61e-06	5.35e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.55e-06	5.27e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.52e-06	5.21e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.51e-06	5.2e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.5e-06	5.18e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.47e-06	5.14e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.32e-06	4.91e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.26e-06	4.83e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.25e-06	4.82e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.2e-06	4.74e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.1e-06	4.59e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.09e-06	4.58e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.96e-06	4.39e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.83e-06	4.19e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.73e-06	4.04e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.69e-06	3.98e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.5e-06	3.7e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.46e-06	3.64e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.39e-06	3.54e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.29e-06	3.39e-05	CbGpPWpGaD
